Apyx Medical (APYX) Net Income towards Common Stockholders (2011 - 2026)
Apyx Medical posted quarterly Net Income towards Common Stockholders of -$2.1 million for Q1 2026, up 49.2% year-on-year from -$1.4 million in Q1 2025, and down 62.28% on a QoQ basis from -$1.3 million in Q4 2025.
Apyx Medical (APYX) has 16 years of Net Income towards Common Stockholders data on file, last reported at -$2.1 million in Q1 2026.
- For the quarter ending Q1 2026, Net Income towards Common Stockholders rose 49.2% year-over-year to -$2.1 million; the trailing twelve-month figure through Mar 2026 stood at -$9.2 million (up 54.24% YoY), and the FY2025 full-year result was -$11.2 million, up 52.22% from the prior year.
- Net Income towards Common Stockholders for Q1 2026 stood at -$2.1 million, down from -$1.3 million in the prior quarter.
- Across five years, Net Income towards Common Stockholders topped out at -$1.0 million in Q2 2023 and bottomed at -$9.6 million in Q4 2023.
- The 5-year median for Net Income towards Common Stockholders is -$4.6 million (2023), against an average of -$4.6 million.
- The widest annual swing landed in 2023, when Net Income towards Common Stockholders jumped 81.3%; it then slumped 543.38% in 2024.
- A 5-year view of Net Income towards Common Stockholders shows it stood at -$6.1 million in 2022, then tumbled by 58.4% to -$9.6 million in 2023, then soared by 51.83% to -$4.6 million in 2024, then surged by 71.93% to -$1.3 million in 2025, then plunged by 62.28% to -$2.1 million in 2026.
- The last three Net Income towards Common Stockholders figures came in at -$2.1 million (Q1 2026), -$1.3 million (Q4 2025), and -$2.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 187,319.30 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 199.50 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Apyx Medical | 174.53 Mn | 143.65 Mn | 7.93 Mn | -2.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.11 Mn |
| Dec 31, 2025 | -1.30 Mn |
| Sep 30, 2025 | -1.98 Mn |
| Jun 30, 2025 | -3.78 Mn |
| Mar 31, 2025 | -4.15 Mn |
| Dec 31, 2024 | -4.63 Mn |
| Sep 30, 2024 | -4.70 Mn |
| Jun 30, 2024 | -6.56 Mn |
| Mar 31, 2024 | -7.58 Mn |
| Dec 31, 2023 | -9.61 Mn |
| Sep 30, 2023 | -4.63 Mn |
| Jun 30, 2023 | -1.02 Mn |
| Mar 31, 2023 | -3.53 Mn |
| Dec 31, 2022 | -6.07 Mn |
| Sep 30, 2022 | -5.80 Mn |
| Jun 30, 2022 | -5.45 Mn |
| Mar 31, 2022 | -5.97 Mn |
| Dec 31, 2021 | -2.01 Mn |
| Sep 30, 2021 | -4.23 Mn |
| Jun 30, 2021 | -4.05 Mn |
| Mar 31, 2021 | -4.91 Mn |
| Dec 31, 2020 | -1.53 Mn |
| Sep 30, 2020 | -3.73 Mn |
| Jun 30, 2020 | -4.69 Mn |
| Mar 31, 2020 | -1.95 Mn |
| Sep 30, 2019 | -4.31 Mn |
| Jun 30, 2019 | -4.30 Mn |
| Mar 31, 2019 | -5.61 Mn |
| Dec 31, 2018 | -3.33 Mn |
| Sep 30, 2018 | 68.47 Mn |
| Jun 30, 2018 | -272,000.00 |
| Mar 31, 2018 | -935,000.00 |
| Dec 31, 2017 | -2.97 Mn |
| Sep 30, 2017 | -1.25 Mn |
| Jun 30, 2017 | -3.87 Mn |
| Mar 31, 2017 | -3.90 Mn |
| Dec 31, 2016 | -523,000.00 |
| Sep 30, 2016 | -964,000.00 |
| Jun 30, 2016 | -519,000.00 |
| Mar 31, 2016 | -1.94 Mn |
| Dec 31, 2015 | -1.41 Mn |
| Sep 30, 2015 | -1.59 Mn |
| Jun 30, 2015 | -1.50 Mn |
| Mar 31, 2015 | 12.86 Mn |
| Dec 31, 2014 | -5.45 Mn |
| Sep 30, 2014 | -2.98 Mn |
| Jun 30, 2014 | 29,000.00 |
| Mar 31, 2014 | -9.81 Mn |
| Dec 31, 2013 | -2.47 Mn |
| Sep 30, 2013 | -341,000.00 |
| Jun 30, 2013 | 2.23 Mn |
| Mar 31, 2013 | -409,000.00 |
| Dec 31, 2012 | 286,000.00 |
| Sep 30, 2012 | -7,000.00 |
| Jun 30, 2012 | 152,000.00 |
| Mar 31, 2012 | 187,000.00 |
| Dec 31, 2011 | -1.03 Mn |
| Sep 30, 2011 | 63,000.00 |
| Jun 30, 2011 | 429,000.00 |
| Mar 31, 2011 | 492,000.00 |